Tras contagiarse, el mandatario de Estados Unidos recibió un cóctel de medicamentos por parte de la farmacéutica Regeneron. Este es un tratamiento experimental. El científico barranquillero Faisal Alfonso Fakih es uno de los principales investigadores en el estudio que está desarrollando la farmacéutica Regeneron para hallar una cura contra el coronavirus COVID-19 . Es precisamente esta compañía …

Read moreColombiano está en grupo de investigadores que trata a Donald Trump contra el COVID-19

“El coronavirus tiene unas espigas y al final unas coronas. Estos anticuerpos cubren esas ‘coronitas’”, dijo en Mañanas BLU el médico Faisal Alfonso Fakih. El médico Faisal Alfonso Fakih habló en Mañanas BLU sobre el Regeneron, el coctel experimental de anticuerpos contra el COVID-19 que se le suministra al presidente de EE.UU., Donald Trump. “Ha sido diseñado …

Read moreAsí es el Regeneron, el coctel experimental de anticuerpos que tomó Trump para COVID-19

A MESSAGE FROM THE PRESIDENT! pic.twitter.com/uhLIcknAjT — Donald J. Trump (@realDonaldTrump) October 7, 2020

Mr. Trump received a single dose of an antibody cocktail made by the biotech company Regeneron. The company’s C.E.O. has known the president for years. President Trump has received a dose of an experimental antibody cocktail being developed by the drug maker Regeneron, in addition to several other drugs, including zinc, vitamin D and the …

Read morePresident Trump Received Experimental Antibody Treatment

The Washington Post (9/30, A1, Johnson) reports many experts think a drug, called a monoclonal antibody cocktail, “could be the best bet to defang the novel coronavirus and transform it from a potentially lethal infection into a treatable illness.” NIH Director Francis Collins said it is “a real best chance of being a game changer.” Meanwhile, Janet Woodcock, …

Read moreExperts think monoclonal antibodies could be best option for COVID-19 treatment

A Regeneron Pharmaceuticals Inc. antibody cocktail may help treat coronavirus patients outside of the hospital by reducing virus levels and symptoms, early study results indicate. In an early-stage clinical trial of 275 Covid-19 patients, those who received Regeneron’s experimental therapy had lower virus levels in the bloodstream seven days later compared with patients who received a placebo, …

Read moreRegeneron Antibody Cocktail Lowers Virus in Covid Patients